Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioblastoma 4 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Melanoma 1 Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

enzalutamide 33 Abiraterone Acetate 29 apalutamide 26 Prednisone 26 Radiotherapy 25 Magnetic Resonance Spectroscopy 25 Androgen Antagonists 24 Leuprolide 22 Radiosurgery 19 darolutamide 18 Docetaxel 17 Gonadotropin-Releasing Hormone 16 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15 Goserelin 13 gallium 68 PSMA-11 12 bicalutamide 12 Specimen Handling 12 Radiotherapy, Intensity-Modulated 12 abiraterone 11 Radiation 11 pembrolizumab 10 Pluvicto 10 Carboplatin 9 Brachytherapy 9 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 9 relugolix 8 luprolide acetate gel depot 8 Triptorelin Pamoate 8 Standard of Care 8 Nivolumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Prostatic Neoplasms × poly ICLC × Clear all

NCT05010200 2026-01-07

PGV-Prostate

Icahn School of Medicine at Mount Sinai

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡